Business
Boston Scientific elects Cathy Smith and Christophe Weber to Board of Directors
Boston Scientific Corporation (NYSE: BSX) announced today the election of Cathy Smith and Christophe Weber to its Board of Directors, effective February 18, 2026.
About this update from Takeda Pharmaceutical Co. Ltd.
[{"type":"text","content":"MARLBOROUGH, Mass., Feb. 23, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of Cathy Smith and Christophe Weber to its Board of Directors, effective February 18, 2026.","length":212,"tagName":"p"},{"type":"image","alt":"Boston Scientific Corporation (PRNewsFoto/Boston Scientific Corporation) (PRNewsFoto/Boston Scientific Corporation)","displaySize":"","headline":null,"caption":"Boston Scientific Corporation (PRNewsFoto/Boston Scientific Corporation) (PRNewsFoto/Boston Scientific Corporation)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":209,"url":"https://media.zenfs.com/en/prnewswire.com/4c1b2f3c814a5ed334b0bdec836a2864"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3wSH3.C6fjYiDWzy8usOhw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM2ODtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/4c1b2f3c814a5ed334b0bdec836a2864","width":400,"height":209}},"href":"https://mma.prnewswire.com/media/2917844/Boston_Scientific_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Smith is a seasoned executive with deep expertise in finance, corporate strategy and operational excellence. She currently serves as chief financial officer of Starbucks. Previously, she held chief financial officer roles at Nordstrom, Bright Health, Target, Express Scripts and Walmart, supporting large, complex organizations through periods of significant growth. Smith currently serves on the board of PPG Industries. She holds an MBA from the University of Southern California and a bachelor's degree in business economics from the University of California, Santa Barbara.","length":581,"tagName":"p"},{"type":"text","content":"Weber brings extensive global leadership experience across the pharmaceutical industry. He is the president and chief executive officer of Takeda Pharmaceutical since April 2015, retiring in June 2026. He joined Takeda in 2014 as president and chief operating officer. Prior to Takeda, Weber held roles of increasing responsibility in multiple countries at GlaxoSmithKline. He has led large-scale transformations grounded in the principles of patient and customer-centricity, helping global organizations operate more effectively while remaining focused on delivering meaningful outcomes for patients. Weber earned a doctorate in pharmacy from Uni...